During the past decade, The Emory Clinic conducted 96 clinical trials. In the 10-year time frame, 96 clinical trials started and 55 clinical trials were completed, i.e. on average, 57.3% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 33 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Emory Clinic" #1 sponsor was "Emory University" with 52 trials, followed by "Pfizer" with 25 trials sponsored, "Celgene" with 4 trials sponsored, "Cytokinetics" with 4 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials sponsored. Other sponsors include 52 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Emory Clinic" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Alzheimer's Association" with 2 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator and "UCB Pharma" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "The Emory Clinic" are "Pulmonary Arterial Hypertension" (5 trials), "Alzheimer Disease" (4 trials), "Amyotrophic Lateral Sclerosis" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials) and "Chronic Heart Failure" (3 trials). Many other conditions were trialed in "The Emory Clinic" in a lesser frequency.

Most popular intervention types in "The Emory Clinic" are "Drug" (100 trials), "Other" (18 trials), "Device" (15 trials), "Behavioral" (9 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "HeartWare® VAS" (3 trials), "Ozanimod" (3 trials), "Placebo oral tablet" (3 trials) and "Rituximab" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Emory Clinic" are 132 trials for "All" genders, 11 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "The Emory Clinic". undefined are not yet recruiting, 18 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 84 completed trials in The Emory Clinic, 1 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in The Emory Clinic, 12 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 33 trials that are defined as “Not Applicable".

The Emory Clinic has several departments that took part in Clinical trials: "Emory University Hospital - Neurology" - 2 trials, "Emory Dermatology Clinic" - 2 trials, "The Emory Clinic, Dept of Urology" - 2 trials